FOLH1 and COVID-19: In prostate cancer patients with asymptomatic COVID-19, 68Ga-prostate-specific membrane antigen (PSMA) PET/CT was used for staging, and the results showed increased metabolism (SUVmax 2.5–3.2) in the ground-glass opacities in the lung [42, 44].